Biblio

Author Title [ Type

] Year

Filters: Author is Tzeng, Yew-Min [Clear All Filters]

Journal Article

Chen J-H, Wu ATH, Tzeng DTW, Huang C-C, Tzeng Y-M, Chao T-Y. Antrocin, a bioactive component from Antrodia cinnamomea, suppresses breast carcinogenesis and stemness via downregulation of β-catenin/Notch1/Akt signaling. Phytomedicine. 2019;52:70-78.

Chen M-Y, Hsu C-H, Setiawan SAgung, Tzeng DTW, Ma H-P, Ong JRuey, Chu YCheng, Hsieh M-S, Wu ATH, Tzeng Y-M, et al. Ovatodiolide and antrocin synergistically inhibit the stemness and metastatic potential of hepatocellular carcinoma via impairing ribosome biogenesis and modulating ERK/Akt-mTOR signaling axis. Phytomedicine. 2022;108:154478.

Lu K-T, Wang B-Y, Chi W-Y, Chang-Chien J, Yang J-J, Lee H-T, Tzeng Y-M, Chang W-W. Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27. Toxins (Basel). 2016;8(5).

Su Y-K, Bamodu OAdebayo, Tzeng Y-M, Hsiao M, Yeh C-T, Lin C-M. Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide. Phytomedicine. 2019;61:152840.

Hsu C-H, Weng P-W, Chen M-Y, Yeh C-T, Setiawan SAgung, Yadav VKumar, Wu ATH, Tzeng DTW, Gong J-X, Yang Z, et al. Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways. Chem Biol Interact. 2022:110329.